Top Markets
#1 Akedo Akedo +70.44%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.33%
#4 Cross Cross +45.97%
#5 Velvet Velvet +34.78%
#6 Black Phoenix Black Phoenix +34.22%
#7 OVERTAKE OVERTAKE +21.57%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#9 Movement Movement +13.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.14%
Coin of the day
Akedo Akedo
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Redx Pharma Plc Redx Pharma Plc

Redx Pharma Plc

REDX
शेयरों में रैंक #38811
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
शेयर मूल्य
$0.20410523
अंतिम समन्वयन: 2024-04-30
मार्केट कैप
$793.94K
बदलाव (1 दिन)
42.54%
बदलाव (1 वर्ष)
0.00%
देश
GB
व्यापार Redx Pharma Plc (REDX)

श्रेणी

Healthcare
Redx Pharma Plc (REDX) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.12 (2024-04-01 को)

दिन का सबसे निम्न समापन मूल्य: $1.26 (2015-03-01 को)
Redx Pharma Plc के स्टॉक मूल्य का इतिहास 2015 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2024 -59.88%
2023 -59.57%
2022 -25.78%
2021 29.62%
2020 711.52%
2019 9.53%
2018 -70.73%
2017 -45.20%
2016 -51.74%
2015 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.52 30.03%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $847.62 29.92%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE